| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |